The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Blomensy 2.5 mg film-coated tablets



EGIS Pharmaceuticals PLCPA1470/006/001

Main Information

Trade NameBlomensy 2.5 mg film-coated tablets
Active SubstancesRivaroxaban
Dosage FormFilm-coated tablet
Licence HolderEGIS Pharmaceuticals PLC
Licence NumberPA1470/006/001

Group Information

ATC CodeB01AF01 rivaroxaban

Status

License statusAuthorised
Licence Issued06/01/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back